BlackRock acquired 3.62M Universal Technical Institute shares worth $163M. That's 0.00% of their equity portfolio (1786th largest holding). The investor owns 7.90% of the outstanding Universal Technical Institute stock. The first Universal Technical Institute trade was made in Q4 2020. Since then BlackRock bought shares twelve more times and sold shares on five occasions. The stake costed the investor $44.1M, netting the investor a gain of 269% so far.
It is estimated that the drug sales could reach an annual value of about 100 crore, in about 2-3 years
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has completed a pivotal phase of its Phase I/II clinical tria…
Universal Technical's (UTI) division relaunches the Summer Ignite program in 2024 in partnership with NAPA to address the shortage of skilled workers in auto...